Expand China tariffs to all products and subsidize onshoring from China
Navarro recommends strategically expanding tariffs to all Chinese products at rates that block Made-in-China goods (paced to protect essential pharma access) plus large financial/tax incentives for firms relocating production from China to the U.S.
Mandate
Mandate Ch. 26 (Trade) — The Case for Fair Trade (Navarro), Policy Responses to Communist Chinese Aggression: strategically expand tariffs to all Chinese products and raise rates to block Made-in-China products at a pace that does not deny essential products like key pharmaceuticals; provide significant financial and tax incentives to American companies seeking to onshore production from Communist China.
Undo plan
1) Rescind blanket China tariff expansions beyond lawful Section 301 findings; restore product-specific remedy process.
2) Repeal special China-onshoring tax credits/subsidies that are not generally available industrial incentives.
3) Maintain targeted trade remedies (AD/CVD, export controls) for documented unfair practices without economy-wide blockade tariffs.
4) Protect essential-goods access via transparent exclusion processes, not permanent high walls.
5) Verify: tariff schedule coverage of China HS lines; Treasury scoring of onshoring credits.